Daily Stock List
Stratex Oil & Gas Holdings, Inc. (STTX)
Wall Street Resources reported recently on Stratex Oil & Gas Holdings, Inc. (STTX), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
OTCQB-listed Stratex Oil & Gas Holdings, Inc. is an independent energy company. Its focus is on the acquisition and subsequent organic exploitation and development of primarily operated crude oil properties. The Company’s present business strategy is to internally identify certain opportunities that could take the form of the purchase of producing properties with meaningful development drilling upside, bolt on acreage and/or production and farm-ins. Stratex Oil & Gas Holdings is based in Salt Lake City, Utah.
The Company is concentrating on mainly crude oil properties in Texas and Kansas, and two proprietary and distinct projects in Utah. These include a vast shale development play and a world-class exploration project, located along the Utah/Wyoming Overthrust. Furthermore, it owns smaller operated and non-operated working interests in North Dakota, Utah, and Montana.
Stratex currently owns an interest in 41 wells; 31 of them account for its current net production and cash flow. It now holds approximately 10,513 net leasehold acres in Sheridan, Roosevelt, Montana, Williams, Billings, Divide, Mountrail, and Stark Counties, North Dakota and Zavaa County, Texas, Sumner and Lane Counties, Kansas, and Juap County, Utah.
At the beginning of December 2014, Stratex Oil & Gas Holdings and Richfield Oil & Gas Company announced the successful completion of the earlier announced merger of a wholly-owned subsidiary of Stratex with and into Richfield. Richfield is now a wholly-owned subsidiary of Stratex. The merger received approval by Richfield's stockholders at a special meeting held on November 24, 2014.
Through combining the complementary asset portfolios of Stratex Oil & Gas and Richfield Oil & Gas Company, Stratex will benefit from drilling program optimization, the elimination of duplicative expenses from operating Richfield as a publicly reporting company, and economies of scale relative to field operations. This acquisition also considerably enhances Stratex's overall acreage position to 109,982 gross acres (27,270 net acres).
Stratex Oil & Gas Holdings, Inc. (STTX), closed Tuesday's trading session at $0.06625, up 32.50%, on 449,017 volume with 49 trades. The average volume for the last 60 days is 70,678 and the stock's 52-week low/high is $0.0456/$0.61.
Max Sound Corp. (MAXD)
TopPennyStockMovers, BUYINS.NET, Greenbackers, and PennyStocks24, reported earlier on Max Sound Corp. (MAXD), and we choose to highlight the Company today, here at the QualityStocks Daily Newsletter.
Max Sound Corp. sells and licenses products and services founded on its Max Sound technology for sound recording and playback. Its focus is on licensing its technology to content creators, manufacturers, and network broadcasters. In essence, MAX-D is to Audio what HD is to Video. Max Sound has its corporate headquarters in Santa Monica, California.
Max Sound serves motion picture, music recording, video game, broadcasting, and Internet video and audio, and consumer electronics markets. The Company’s technologies include MAX-D HD Audio and VSL's Optimized Data Transmission Technology. Its patent pending technology is hardware/platform agnostic. There is no need for a user to change or add equipment.
The MAX-D HD Audio technology has over 70 filed patents pending. It now can now be found on Qualcomm’s Snapdragon DSP Processors. Qualcomm produces over 750 million chips each year, and represents 8 billion dollars of the worldwide chip market.
MAX-D HD remains one-tenth the size of a WAV file. Research & Development (R&D) of the MAX-D HD Audio Technologies continues to be Max Sound’s primary focus now that it has entered its licensing phase.
Max Sound now has a MAX-D API (Application Programming Interface). It permits the MAX-D HD proprietary algorithm and coding to be inserted into applications. These include streaming services, automotive head units, DSP memory in speakers, developer platforms, and web-based applications.
Max Sound markets Max Sound technology. The MAX-D Audio Process makes everything sound better. It can convert any audio file to high-definition (HD) quality without increasing its file size. The technology improves different types of audio, and also compressed audio and video as used in mp3 files, iPods, Internet, and satellite/terrestrial broadcasting.
MAX-D is a proprietary audio process. It restores lost, compressed sound harmonics and brings HD sound to digital media. MAX-D improves the sound a listener hears from any device through restoring the lost, compressed sound in real time. This is without increasing the file size.
Earlier this month, Max Sound announced the results of its Scientific Sound Study. The University of Florida's College of Speech, Language and Hearing Science recently completed a blind study assessing preferred music styles and audio levels among 70 research participants, to assess what impact MAX-D has on these preferences. Consumers preferred MAX-D HD Audio for safe listening Volume and Sound Quality. The University of Florida's College of Speech, Language and Hearing Science is a global leader in auditory neuroscience.
Max Sound Corp. (MAXD), closed Tuesday's trading session at $0.0269, down 0.37%, on 881,060 volume with 18 trades. The average volume for the last 60 days is 1,144,538 and the stock's 52-week low/high is $0.023/$0.2845.
Optex Systems Holdings, Inc. (OPXS)
Epic Stock Picks reported yesterday on Optex Systems Holdings, Inc. (OPXS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Optex Systems Holdings, Inc. is a top manufacturer of optical sighting systems and assemblies principally for Department of Defense (DoD) applications. It also manufactures and delivers many periscope configurations, rifle and surveillance sights, and night vision optical assemblies. The Company delivers its products directly to the military services and to prime contractors. Founded in 1987, Optex Systems Holdings has its headquarters in Richardson, Texas. Optex Systems, Inc. is a wholly-owned subsidiary of Optex Systems Holdings.
The Company’s products are installed on varied kinds of U.S. military land vehicles. These include the Abrams and Bradley fighting vehicles, Light Armored and Armored Security Vehicles. Moreover, Optex’s products have been selected for installation on the Stryker family of vehicles.
Optex Systems manufactures the US Navy 20x 120mm Ship Binoculars and also brings innovative technology to vehicular mounted sighting systems. Its dismounted sighting systems work on weapon sights, night vision goggles, and any other sighting requirements outside of ships and land vehicles. The Company can also meet Commercial (non-military) needs.
Optex Systems’ products include its Laser Protected Periscopes. The Optex periscopes come with optional laser protection in both glass and plastic. This is to protect soldiers’ eyes as they do battle from different vehicle platforms, including the Bradley, Stryker Family, and the M60 tank varieties.
The Company’s products also include the Muzzle Reference Sensor. It allows for consistent accuracy during repeated fire by calibrating the tank barrel to the sighting system. Optex sensors are used in the Abrams A1, A2, Korean K1 and the Stryker Main Gun System.
Optex Systems’ products also include its DDAN/M36 Sights. It permits soldiers safer and more efficient field performance with the user-friendly digital displays and optional laser protection. Optex Systems’ M36E3 combines day and night sights into one smaller device, which smoothly adjusts to any change in lighting.
This past November, Optex Systems Holdings reported the completion of the acquisition of Applied Optics Center (AOC) Division of Warrior Systems Sector with the Electronics Systems Business Segment of L-3 Communications Corp.
In November, Mr. Danny Schoening, CEO of Optex, stated, "Optex Systems is pleased to join forces with the AOC Team and the products and skills that they bring to the new organization. Optex Systems and AOC have been associated on a supply basis for over 20 years and to now have shared synergy in optical coatings and sighting systems is extremely exciting."
Optex Systems Holdings, Inc. (OPXS), closed Tuesday's trading session at $0.0145, up 14.17%, on 619,930 volume with 28 trades. The average volume for the last 60 days is 200,103 and the stock's 52-week low/high is $0.0081/$0.0373.
WindStream Technologies, Inc. (WSTI)
PHUB News, Hot Stock Profits, DSR News, Value Penny Stocks, Winston Small Cap, Impressive Penny Stocks, and Pennystocktweeters.com reported earlier on WindStream Technologies, Inc. (WSTI), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Founded in 2008, WindStream Technologies, Inc. established to create low-cost hybrid, renewable energy solutions for urban, suburban, and on and off-grid environments. Its patented SolarMill® technology is a distributed energy solution. SolarMill® produces continuous renewable energy for customers 24/7, 365 days a year. WindStream formed with the objective of designing, prototyping, and manufacturing affordable and scalable renewable energy technologies for the worldwide market. WindStream Technologies has its headquarters in North Vernon, Indiana.
The Company has developed and tested the first-of-its-kind, integrated, hybrid energy solution. WindStream Technologies is now marketing and selling the SolarMill® (made in the U.S.) to a global customer base. Its patented SolarMill® products consist of Vertical Axis Turbines and Solar Panels controlled by WindStream's proprietary "smart" electronics.
WindStream has set up its India/South Asia Operations under the name of WindStream Energy Technologies, Pvt. Ltd. This is with the goal of serving that region with products manufactured in India under the close inspection of WindStream USA. WindStream Technologies will continue to manufacture and ship its products internationally from its facilities in Indiana.
WindStream had its official launch of the proprietary WindStream UPS eMPOWER system for Jamaica Public Services (JPS) in May 2014. In June 2014, WindStream signed several new distribution agreements. This expands the Company’s reach into new territories worldwide to include Turkey, Netherlands, New Zealand, Ghana, Liberia, Kenya, and Tanzania.
WindStream Technologies announced in December 2014 that it closed a Joint Venture (JV) agreement with West Coast Ventures (India) Pvt. Ltd., (WCV) based in Chennai, India and a group of strategic investors. The new entity, DEEPAN Energy Venture LLP, has committed $2 million dollars for an equity stake in the JV, which will form a manufacturing and distribution presence in India and South Asia.
WindStream Technologies has broken ground on its 50,000 sq. ft. manufacturing facility outside of Hyderabad, India. The new facility will be the Company's second manufacturing plant focused on building its proprietary SolarMill® products and designed to service the India and South Asia markets. This month, WindStream Technologies announced that it is on schedule to open this manufacturing facility outside of Hyderabad, India the first week of April 2015.
WindStream Technologies, Inc. (WSTI), closed Tuesday's trading session at $0.068, up 4.45%, on 166,108 volume with 25 trades. The average volume for the last 60 days is 171,817 and the stock's 52-week low/high is $0.0651/$2.25.
Praxsyn Corp. (PXYN)
Profit Status reported recently on Praxsyn Corp. (PXYN), and we are reporting on the Company as well, here at the QualityStocks Daily Newsletter.
Praxsyn Corp. centers on providing custom compounded non-narcotic, transdermal topical pain medications to industrial health physicians and clinics. At present, the Company formulates transdermal creams in its compounding pharmacy, Mesa Pharmacy. It has developed a series of topical ointments for pain relief. Praxsyn is working on establishing its Point of Care/In-Office Dispensing Program, and its’ In-Office Toxicology Testing.
The Company was previously known as The PAWS Pet Company, Inc. It changed its corporate name to Praxsyn Corp. in March 2014. NexGen Med Solutions, LLC is a wholly-owned subsidiary of Praxsyn. Praxsyn’s shares trade on the OTC Markets Group’s OTCQB. The Company is based in Irvine, California.
The Company’s Point-Of-Care Services will provide the health care provider with pharmaceuticals and testing services that are convenient and easy for physicians and staff. Its wholly-owned subsidiary, Mesa Pharmacy, Inc., provides doctors with an alternative to oral pain medications. Mesa Pharmacy concentrates on providing custom compounded non-narcotic, transdermal topical pain medications. These are marketed to industrial health physicians and medical clinics.
Mesa Pharmacy has developed a series of topical creams, in different strengths. The transdermal creams are tailored to patients suffering from long-term pain associated with work place related injuries.
Praxsyn, by way of subsidiary Mesa Pharmacy, provides a series of formulations that are compounded by using Food and Drug Administration (FDA) approved pain medications formulations to help patients suffering from pain associated with injuries. Via compounding, a patient can receive medication precisely formulated for his or her needs and medical history.
Praxsyn’s NexGen Med Solutions is a billing and collections company. It recently formed to enable Praxsyn to manage its accounts receivables in a more cost-effective and efficient manner. The anticipation is that the new subsidiary will provide an integrated alternative to previous billing and collections procedures.
Praxsyn, Mesa Pharmacy’s parent, has started to process Preferred Provider Organization (PPO) prescriptions. Mesa Pharmacy’s commitment is to providing medical practitioners with medications for patients through this move into the PPO network with its new and advanced products. Mesa has now expanded its innovative and non-addictive product line beyond topical creams to also include capsules, patches, and shampoos.
This month, Praxsyn announced that Mesa Pharmacy has final committed amounts in excess of $4 million for approved PPO claims dating from February 1, 2015 through February 28, 2015 from 15 of its 28 licensed states nationwide. The commitment of these claims has been accomplished through its earlier announced marketing agreement with NHS Pharma, Inc. Marketing and billing costs are still applicable at industry standards of 55 percent of the total amount billed.
Furthermore, this month, Mesa Pharmacy announced that, as of February 12, 2015, Dr. Amy Lee (Hawkins) Summers, Pharm, D., joined the Company as its new Pharmacist in Charge (PIC) and Director of Pharmacy. Dr. Summers is a compounding expert and a bioidentical hormone specialist.
Praxsyn Corp. (PXYN), closed Tuesday's trading session at $0.0335, down 2.62%, on 714,900 volume with 23 trades. The average volume for the last 60 days is 974,991 and the stock's 52-week low/high is $0.03/$0.175.
Cannabis Science, Inc. (CBIS)
InvestorPlace, Greenbackers, The Street, and TopPennyStockMovers reported recently on Cannabis Science, Inc. (CBIS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Cannabis Science, Inc. specializes in cannabis formulation-based drug development. The Colorado Springs, Colorado-based Company is at the vanguard of cannabinoid research for the development of cannabis-based medicines to satisfy unmet medical needs. It leverages its unique understanding of metabolic processes to provide novel treatment approaches to many illnesses for which present treatments and understanding remain unsatisfactory.
Its products are medical cannabinoid products. These undergo development from one or more of the cannabinoid compounds found in the cannabis plant. Cannabis sativa is one of the most widely used plants for recreational and medicinal purposes. Cannabis Science’s future endeavors include Pain Management, Arthritis, and Post Traumatic Stress Disorder in the country’s veterans.
Cannabis Science creates cannabinoid-based extract formulations for different medical conditions. These include more than eight different types of Cancer. The Company works with top experts in drug development, medicinal characterization and clinical research to develop, produce, and commercialize novel therapeutic approaches for the treatment of illnesses caused by infections and for age-related illnesses. Its initial emphasis is on skin cancers, HIV/AIDS, and neurological conditions.
CS-S/BCC1 is in preparation to enter Phase I clinical trials within one to two years. The formulation of this product is for topical administration to be tested in a Phase I study, with an indication for skin cancer. CS-TATI-1 is in preclinical development with the indication for infectious disease. Data by researchers at the Mount Sinai School of Medicine found that cannabinoids inhibit TAT induced migration to TAT through cannabinoid 2 receptors (CB2). This has potential applications in HIV and other infectious diseases.
Regarding its CS-NEURO-1, the Company indicates that first formulation of it in the series of neurobehavioral disorder-targeted products is in pre-clinical development with promising clinical results. Cannabis Science’s plan is to use the invention in food products via a licensing agreement with a partner company. It also plans to move ahead concurrently with pharmaceutical grade development in Europe and North America.
This month, Cannabis Science reported key progress with its subsidiary, Michigan Green Technologies (MGT).
Mr. John Dalaly, CEO of Michigan Green Technologies, stated, "MGT has continued to work with key legislators in Michigan to rectify the Michigan Medical Marihuana Act of 2008. Michigan's medical cannabis program has not seen the success in other states and if proper legislation can be implemented then a proper cannabis economy with integrity can begin to function, we believe we are playing a key role in this outstanding progress. The participants will flourish under proper legal protection that law enforcement can embrace, and the State of Michigan and its citizens will benefit substantially."
Cannabis Science, Inc. (CBIS), closed Tuesday's trading session at $0.0478, down 1.85%, on 3,138,504 volume with 243 trades. The average volume for the last 60 days is 4,638,485 and the stock's 52-week low/high is $0.0333/$0.1872.
Rich Pharmaceuticals, Inc. (RCHA)
PennyStockRumors.net, Actual Gains, PricelessPennyStocks, 007 Stock Chat, PennyStockSpy, and TopPennyStockMovers reported recently on Rich Pharmaceuticals, Inc. (RCHA), and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.
Rich Pharmaceuticals, Inc. is a Biopharmaceutical Company based in Beverly Hills, California. It is developing a treatment for Acute Myelocytic Leukemia (AML)/white blood cell elevation and other blood related diseases. The Company is focusing on the development of its lead product, RP-323 (12-O-tetradecanoylphorbol-13-acetate), for the treatment of acute myelogenous leukemia (AML) in refractory patients. Rich’s aim is to extend refractory patients life expectancy and increase quality of life.
The design of Rich Pharmaceuticals’ RP-323 is to treat blood and cancer related diseases by way of non-evasive outpatient facilities. Overall, it is centering on the discovery, development, as well as commercialization of drugs to treat unmet medical needs in oncology that function at the DNA level. The Company’s mission is to develop these small-molecule compounds to treat cancer and stroke in patients with the greatest unmet medical needs.
Rich Pharmaceuticals has entered into an agreement with Richard L. Chang Holdings, LLC, headquartered in New Jersey, for ownership to its investigational cancer patent assignment using Phorbol Esters in the treatment of Hodgkin's Lymphoma. Hodgkin lymphoma is a cancer of the immune system, marked by the presence of a kind of cell called the Reed-Sternberg cell.
With this agreement, Rich Pharmaceuticals will obtain complete ownership and all interest in the indication, patents, and intellectual property (IP) related to treatment of Hodgkin's Lymphoma, utility patent application number 61998397, entitled Compositions And Methods Of Use Of Phorbol Esters For The Treatment Of Hodgkin's Lymphoma.
Today, Rich Pharmaceuticals announced that it entered into a Letter of Intent (LOI) with The Faculty of Medicine at Khon Kaen University, Thailand to conduct clinical trials using the Company’s lead molecule, RP-323 in treating AML patients. The estimation is that the clinical studies will include 36 patients and 3 separate sites.
Mr. Ben Chang, Rich Pharmaceuticals’ Chief Executive Officer, said, "As we move closer to beginning our AML clinical program, we are continuing to work diligently in securing additional principal investigators in the United States and finalizing our IND submission to the FDA."
Rich Pharmaceuticals, Inc. (RCHA), closed Tuesday's trading session at $0.0011, down 8.33%, on 147,449,834 volume with 343 trades. The average volume for the last 60 days is 45,196,371 and the stock's 52-week low/high is $0.0008/$0.455.
Sparta Commercial Services, Inc. (SRCO)
The QualityStocks Daily Newsletter would like to spotlight Sparta Commercial Services, Inc. (SRCO). Today, Sparta Commercial Services, Inc. closed trading at $0.051, on 735,480 volume with 43 trades. The stock’s average daily volume over the past 60 days is 139,707, and its 52-week low/high is $0.05/$1.25.
Sparta Commercial Services, Inc. reported today that the customer base for its iMobileApp product continues to expand, illustrating that businesses across the country are acknowledging the increasing value that iMobileApp offers. The wide range of companies using the iMobileApp to communicate with their customer base further attests to the increasing need for businesses to adopt new technology to remain competitive.
Sparta Commercial Services, Inc. (SRCO) is a New York-based technology company whose subsidiary, Specialty Reports, Inc., is a leader in developing, managing, and servicing custom mobile apps for small and medium sized businesses as well as for retail vehicle dealers, in addition to providing motor vehicle title history reports to dealers, insurance companies, financial institutions, consumers, and other interested parties. Sparta Commercial Services also offers and administers vehicle and capital equipment lease financing programs for municipalities.
iMobileApp.com develops and services customized mobile applications for powersports, automobile, recreation vehicle, marine, and agriculture equipment dealers as well as for racetracks, restaurants, liquor stores, schools and any other small to medium sized company. The iMobileApp allows businesses to stay in touch with their customers, to notify them of upcoming and ongoing promotions, special events, and provide them with the ability to view new and used inventory, communicate directly with the service department, and more. The mobile application is generated, packaged, and made available on-line, at no cost to the company's customers, through the Apple App Store and the Google Play Store.
The company also serves as a one-stop online source for various types of vehicle title history reports, including motorcycles, recreation vehicles, automobiles, light trucks, and commercial (heavy duty) trucks. Its online history report products include Cyclechex.com, a motorcycle vehicle title history report provider; RVchecks.com, a RV vehicle title history report provider; and CarVinReport.com, an automobile and light truck vehicle title history report provider, and TruckChex.com, a commercial (heavy duty) truck vehicle title history report provider.
In addition to consumers – both buyers and sellers – vehicle dealerships, insurance companies, financial institutions and others benefit from the information provided on these vehicle title history reports. The Specialty Reports, Inc. vehicle title history reports are featured online at NADAGuides.com, KBB.com and DMV.org, prominent online sources for pre-owned vehicle values and other important information for both buyers and sellers.
The company’s Municipal Lease Financing Program for local and/or state agencies throughout the country provides an economical way to finance essential equipment, from police motorcycles and cruisers to EMS equipment and busses, to virtually any type of equipment required. The lease purchase financing program receives considerable praise for its understanding of government acquisition procedures and its work with a wide range of vendors.
Sparta Commercial Services is an innovative and diversified company that has proven its ability to identify the needs and interests of its targeted markets, as well as develop products and services specifically designed to meet those needs and interests now and well into the future. With a full suite of offerings that address the challenges of the powersports, recreation, and auto industries, the company is well positioned to achieve strong future growth rates. Disclaimer
Sparta Commercial Services, Inc. Company Blog
Sparta Commercial Services, Inc. News:
iMobileApp's Customer Base Continues to Diversify
Sparta Commercial Reports Continued Sales Growth
iMobileApp's Customer Base Continues to Grow and Broaden
Sibling Group Holdings, Inc. (SIBE)
The QualityStocks Daily Newsletter would like to spotlight Sibling Group Holdings, Inc. (SIBE). Today, Sibling Group Holdings, Inc. closed trading at $0.0979, up 39.66%, on 269,020 volume with 15 trades. The stock’s average daily volume over the past 60 days is 106,357, and its 52-week low/high is $0.05/$0.24.
Sibling Group Holdings, Inc. announced today that its subsidiary, Urban Planet Mobile™ (UPM) has entered into a global partnership with Rivers Media Group, LLC, a global music label and branded entertainment content provider. Rivers Media Group Founder & CEO, Carmen Key, has a list of platinum hits under her belt stemming from her work with Roc Nation & today's elite in music. She has taken part in the development and success of careers like David Guetta, Selena Gomez, Flo Rida, Zendaya Coleman and more. Commenting on the partnership with Urban Planet Mobile, Carmen Key said, "I am thrilled to be joining forces with Urban Planet Mobile to deliver high quality music and entertainment to consumers around the world."
Sibling Group Holdings, Inc. (SIBE) is enhancing and delivering 21st century learning with advanced technology and education management operations. Accessing funds from the public capital markets is part of the company’s unified strategy to accelerate the improvement of Pre-K, K-12 and post-secondary education around the world. Better educated children and adults, sustainable and cost effective instructional models, and reduced dependence on governmental funding are the end results.
Existing offerings include professional development for the teaching profession; educational technology, including classroom management tools; a comprehensive and flexible online curriculum; an aggregation platform for massive open online courses, and academic and skills credentialing. Investments are being made in specialized curriculum such as STEM (science, technology, engineering and math), ESL (english as a second language), SEL (social and emotional learning), and Special Ed aimed at supporting students with special needs and their teachers.
Sibling Group is acquiring various Ed-tech businesses and components with the goal of building the first complete solution for the delivery and management of educational content, and tracking educational results, in the digital media – from curriculum to course certification. The recent acquisition of Blended Schools Network (BSN), which serves over 160 school districts with 300,000 course enrollments and currently offers 212 different online courses, is a great example and has provided Sibling Group with extensive infrastructure and solid groundwork for growth in a rapidly growing industry.
IBIS Capital is forecasting fifteen-fold growth in the e-learning market over the next 10 years and has even suggested that under certain circumstances the transition to digital education may be quicker and more disruptive than ever observed in the media industry. With a strong, highly experienced management team, Sibling Group is in a unique position to continue expanding its portfolio through additional acquisitions and fundamental growth. Disclaimer
Sibling Group Holdings, Inc. Company Blog
Sibling Group Holdings, Inc. News:
Sibling Group's Urban Planet Mobile and Rivers Media Group Announce Global Partnership to Deliver Music & Branded Entertainment
Sibling Group Announces Strategic Partnership for Global Growth; $3.75 Million Investment to Grow Business in China and Other Markets
Sibling Group's Urban Planet Mobile Announces Partnership for Writing Planet in Hong Kong Secondary Schools
Inventergy Global, Inc. (INVT)
The QualityStocks Daily Newsletter would like to spotlight Inventergy Global, Inc. (INVT). Today, Inventergy Global, Inc. closed trading at $0.84, up 2.44%, on 270,663 volume with 279 trades. The stock’s average daily volume over the past 60 days is 289,148, and its 52-week low/high is $0.3904/$12.1798.
Inventergy Global, Inc. (INVT) is an intellectual property (IP) licensing partner specializing in IP value creation. Led by industry veteran Joe Beyers, former head of global licensing for Hewlett-Packard, Inventergy identifies, acquires and licenses patented technologies to help market-leading technology companies monetize and achieve more value from their innovations.
With more than 100 years of combined experience and track record of handling more than $15 billion in IP and technology transactions, Inventergy’s team of professionals handle every aspect of the IP business, from valuation and branding through legal analysis, decision making and patent sales.
Inventergy partners with world-class, market-significant companies who may lack internal manpower, budget or other resources necessary to realize appropriate return-on-investment. Through collaborative, business-centered, and forward-thinking strategies, Inventergy is able to create portfolios with significant market potential and optimize the innovator’s overall return-on-investment.
The company has established a network of key industry relationships to complement its solid licensing model and growing portfolio of assets, which currently stands at more than 760 global patent assets. Inventergy pursues maturing telecommunications technologies already adopted in the marketplace and earning accretive value. Disclaimer
Inventergy Global, Inc. Company Blog
Inventergy Global, Inc. News:
Inventergy Announces Operational Restructuring of Its Product Businesses Designed to Improve Margins, Cash Flow and Earnings Growth
Inventergy Launches Standardized Licensing Initiative for Mobile Device Manufacturers
Inventergy Invited to Present at the 27th Annual ROTH Conference
IFAN Financial, Inc. (IFAN)
The QualityStocks Daily Newsletter would like to spotlight IFAN Financial, Inc. (IFAN). Today, IFAN Financial, Inc. closed trading at $0.326, off by 1.21%, on 327,993 volume with 86 trades. The stock’s average daily volume over the past 60 days is 579,787, and its 52-week low/high is $0.0114/$1.01.
IFAN Financial, Inc. (IFAN) and its wholly owned subsidiaries, iPIN Technologies and Mobicash America, are engaged in the design, development and distribution of software that enhances and enables mobile payments. The San Diego-based company has a growing portfolio of solutions, including the ability to use a debit card and corresponding PIN number while purchasing online via mobile phone, tablet, or computer and peer-to-peer cash transfers.
Keeping pace with the evolution of the information and communication (ICT) market, iPIN Technologies intends to provide a range of processing services for the industry’s future devices. The company is currently developing a new method of online selling through debit card payments and processing. iPIN technology attaches to any smartphone through the headphone jack and converts the device into a consumer PIN debit, same-as-cash payment solution. Using the iPIN Debit app, transactions are processed through the private and secure iPIN Technologies Network.
Mobicash America is an early-stage technology company that develops mobile payment solutions. The company’s platform product, Quidme, utilizes the text messaging function of a mobile phone, allowing the technology to operate on almost any phone or network, with or without data service. The functionality of the Quidme platform allows users to pay bills, purchase goods and services, and to send money to friends and relatives located locally or internationally via simple text message.
IFAN Financial continues to explore opportunities to expand its product portfolio to meet the growing demands for consumer/merchant convenience, speed and security within the mobile commerce market. Products in development will combine the functionality of social media, e-commerce and banking with the broader conveniences of the mobile environment. Disclaimer
IFAN Financial, Inc. Company Blog
IFAN Financial, Inc. News:
IFAN Financial Applauds Facebook's Move Into the Mobile Payments Industry, Foresees Ancillary Opportunities
IFAN Financial Begins Beta Testing With Nation's Largest Debit Card Acquiring Processor
IFAN Financial Reaches Technology Development Milestones
Mobile Lads Corp. (MOBO)
The QualityStocks Daily Newsletter would like to spotlight Mobile Lads Corp. (MOBO). Today, Mobile Lads Corp. closed trading at $0.12, up 9.09%, on 160,191 volume with 16 trades. The stock’s average daily volume over the past 60 days is 34,421, and its 52-week low/high is $0.091/$0.42.
Mobile Lads Corp. (MOBO) designs and delivers secure, wide-area wireless transaction software solutions for the consumer finance, web and health payment processing sectors. The company’s solutions provide streamlined, continuous access to time-sensitive information and data on multiple network standards. Mobile Lads’ products and services, offered through its Xtreme Mobility division, centers on three core technologies that simplify and secure wireless communications: xmVerify, xmBilling, and xmOne.
xmVerify is a real-time mobile transaction security service that prevents credit card fraud by giving users control over the authorization process when making purchases. Using one of the best cryptographic services, and in compliance with most all available platforms, xmVerify sends a transaction authorization request directly to the user’s mobile phone to ensure authenticity.
xmBilling is a mobile platform that provides customers with a convenient and secure way to review and authorize automatic billing transactions, easing the challenges of automated and volume-based billing. The system sends the user a text message with a URL leading to an online e-bill where they can review details of the bill and authorize the payment via credit card with the use of their PIN number.
The xmOne mobile platform provides an array of encrypted mobile services, including top-up, payment processing, emergency notification and marketing, ideal for students and higher education facilities. xmOne interfaces with a school’s existing campus card account system to enable students to perform a variety of banking transactions from their cell phones. The university or college benefits from increased usage of the flex-dollar ecosystem, reduces overhead from ADMs, and can be customized to each school’s individual brand.
Mobile Lads is guided by a management team with a unique blend of in-depth technical expertise in wireless channel communications and a solid background in business strategy and consumer analysis. The company’s vision is to grow as a leading-edge wireless solution provider by enabling innovative, wide-area communication solutions on a global scale. Disclaimer
Mobile Lads Corp. Company Blog
Mobile Lads Corp. News:
Mobile Lads Purchases Majority of North American Shopping Network From Domark International
Mobile Lads to Launch CouBox, a Next-Generation Mobile Coupon Application
Mobile Lads Acquires Innovative Online Coupon Platform, CouBox
Consorteum Holdings, Inc. (CSRH)
The QualityStocks Daily Newsletter would like to spotlight Consorteum Holdings, Inc. (CSRH). Today, Consorteum Holdings, Inc. closed trading at $0.002, even for the day. The stock’s average daily volume over the past 60 days is 91,854, and its 52-week low/high is $0.0013/$0.018.
Consorteum Holdings, Inc. (CSRH) has spent the last 3 years developing relationships and licensing agreements to take the center stage in the emerging market of mobile gaming. The company has the capability to deliver rich mobile content to end users who will use their smart phones in ways that could not even have been imagined five years ago.
Specializing in delivery of mobile content, mobile payment solutions and products through a mix of on-deck partnerships, license agreements, and joint venture revenue share arrangements, the company operates as a technology and services aggregator to meet the diverse needs of its client base. This approach enables unparalleled flexibility when sourcing solutions, resulting in smarter, faster deployment of technologies, competitive pricing, and potential for new streams of revenue.
ThreeFiftyNine Inc., a wholly owned subsidiary, hired a software development team that had previously designed the world’s first regulatory compliant mobile platform for delivery of gaming content created by a third party. The platform, which has met the rigorous standards of the Nevada Gaming Board, the gold standard in regulatory gaming, represents the first generation software delivery platform for mobile devices. The development team spent the past 5 years and millions of dollars in non-recurring engineering costs to complete the development of the platform. At the heart is the capability to deliver any digital content across any cellular network to any mobile device. This key differentiator makes it possible for Consorteum to approach many different markets that are in the business of providing mobile connectivity and mobile content.
Consorteum’s mobile initiatives will benefit multiple business verticals. The company has strategically designed its business initiatives to create repetitive transactions on an ongoing basis. Consorteum's goal is to have their customers think of them more as partners, rather than just technology providers, for longer-lasting, more profitable relationships. Disclaimer
Consorteum Holdings, Inc. Company Blog
Consorteum Holdings, Inc. News:
Consorteum Holdings Signs License Agreement With NYG Holdings
Consorteum Holdings Signs Mobile Application Development Contract With Bet Butler Limited
Consorteum Holdings Launches New Mobile Results App for Popular Keno Game
VistaGen Therapeutics, Inc. (VSTA)
The QualityStocks Daily Newsletter would like to spotlight VistaGen Therapeutics, Inc. (VSTA). Today, VistaGen Therapeutics, Inc. closed trading at $9.00, even for the day, on 114 volume with 3 trades. The stock’s average daily volume over the past 60 days is 646, and its 52-week low/high is $3.16/$15.00.
VistaGen Therapeutics, Inc. (VSTA) is a biotechnology company applying stem cell technology for drug rescue and cell therapy. Drug rescue combines human stem cell technology with modern medicinal chemistry to generate new chemical variants ("drug rescue variants") of once-promising drug candidates that have been discontinued during late-stage preclinical development due to heart or liver safety concerns. VistaGen also focuses on cell therapy, or regenerative medicine, which includes repairing, replacing or restoring damaged tissues or organs
VistaGen's versatile stem cell technology platform, Human Clinical Trials in a Test Tube™, has been developed to provide clinically relevant predictions of potential heart and liver toxicity of promising new drug candidates long before they are ever tested on humans.
By more closely approximating human biology than conventional animal studies and other nonclinical techniques and technologies currently used in drug development, VistaGen's human stem cell-based bioassay systems can improve the predictability of the drug development cycle and lower the cost of new drug research and development by identifying product failures earlier in the cost curve. According to the Food and Drug Administration even only a ten percent improvement in predicting failure before clinical trials could save $100 million in development costs, which savings ultimately could be passed on to patients.
Using mature human heart cells produced from stem cells, VistaGen has developed and internally validated CardioSafe 3D™, a novel three-dimensional (3D) bioassay system for predicting the in vivo cardiac effects of new drug candidates before they are tested in humans. VistaGen is now focused on using CardioSafe 3D™ to generate up to two new, safer small molecule drug rescue variants every twelve to eighteen months. VistaGen anticipates that these drug rescue variants will be modified versions of once-promising new drug candidates that have been discontinued by pharmaceutical companies and academic research institutions because of heart toxicity concerns, despite substantial prior investment and positive efficacy data demonstrating their potential therapeutic and commercial benefits. In most cases, VistaGen plans to license or sell its new, safer drug rescue variants in strategic partnering arrangements with global pharmaceutical companies, arrangements providing VistaGen with both near term and downstream milestone payments and economic participation rights but without future development cost obligations.
AV-101, VistaGen's lead small molecule prodrug candidate, has successfully completed Phase I clinical development in the U.S. for treatment of neuropathic pain, a serious and chronic condition affecting millions of people worldwide, depression, and other neurological diseases and conditions. To date, the U.S. National Institutes of Health (NIH) has awarded VistaGen over $8.75 million for development of AV-101. Management anticipates strategically out-licensing AV-101 to a development and marketing partner in 2013.
VistaGen is also developing LiverSafe 3D™, a novel predictive liver toxicity and drug metabolism bioassay system for drug rescue applications. In parallel with drug rescue activities, the Company is funding early-stage nonclinical studies focused on potential cell therapy applications of its Human Clinical Trials in a Test Tube™ platform. Disclaimer
VistaGen Therapeutics, Inc. Company Blog
VistaGen Therapeutics, Inc. News:
VistaGen and NIH Sign Agreement for NIH-Sponsored Phase 2 Study of Orally-Active AV-101 in Major Depressive Disorder
Dr. Gerard Sanacora Joins VistaGen's Clinical and Scientific Advisory Board
VistaGen Signs Letter of Intent With National Institute of Mental Health for NIH-Sponsored Phase 2 Clinical Study of AV-101 in Major Depressive Disorder
Today's Top 3
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Car Monkeys Group (CKMY) Announces Engagement of QualityStocks Investor Relations Services
- Cleartronic, Inc. (CLRI) Adds Shareholder Value With Cancellation of Two Billion Shares of Common Stock Held by CEO
- Consorteum Holdings, Inc. (CSRH) Signs License Agreement With NYG Holdings
- Dominovas Energy Corp. (DNRG) Key Management Featured in Exclusive QualityStocks Interview
- eCareer Holdings, Inc. (ECHI) Reports 1000% Increase in Openreq.com Site Traffic, Seeks to Expand Salesforce
- Falcon Crest Energy (FCEN) Acquires Remaining Working Interest in Rocky Ford Field
- IFAN Financial, Inc. (IFAN) Applauds Facebook's Move Into the Mobile Payments Industry, Foresees Ancillary Opportunities
- International Stem Cell Corp. (ISCO) Receives Key Stem Cell Patent in Japan
- Inventergy Global, Inc. (INVT) Announces Operational Restructuring of Its Product Businesses Designed to Improve Margins, Cash Flow and Earnings Growth
- MIT Holding, Inc. (MITD) Launches New Website with Investor Relations Suite
- Mobile Lads Corp. (MOBO) Purchases Majority of North American Shopping Network From Domark International
- One World Holdings, Inc. (OWOO) One World Doll Project to Announce National Retail Store Roll Out of the Prettie Girls! Dolls On April 6 Conference Call
- Pure Hospitality Solutions, Inc. (PNOW) Photo Share To Boost Oveedia Valuations
- Save The World Air, Inc. (ZERO) Reports 2014 Year-End Financial Results and Provides Operational Update
- Sibling Group Holdings, Inc. (SIBE) Urban Planet Mobile and Rivers Media Group Announce Global Partnership to Deliver Music & Branded Entertainment
- Sparta Commercial Services, Inc. (SRCO) iMobileApp's Customer Base Continues to Diversify
- Start Scientific, Inc. (STSC) Signs Farmout Agreement With Durban Energy
- VistaGen Therapeutics, Inc. (VSTA) and NIH Sign Agreement for NIH-Sponsored Phase 2 Study of Orally-Active AV-101 in Major Depressive Disorder
- Well Power Inc. (WPWR) to host second webinar on proprietory micro-refinery technology
- Zenosense, Inc. (ZENO) Hospital Collaboration - 400 Person Lung Cancer Detection Trial